Richard A Lake

4PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 19, 2022
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice.

Rachael M Zemek, Wee Loong Chin, Vanessa S Fear

|Jan 29, 2021
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers.

Alistair M Cook, Alison McDonnell, Michael J Millward

|Jul 19, 2019
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment.

Rachael M Zemek, Emma De Jong, Wee Loong Chin

Pageof 1